Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mohan Dutt

Sleep Medicine Sylvania, OH Medical Doctor

NPI 1912320425 CMS profile 4522371

5308 Harroun Rd Ste 180, Sylvania, OH 43560

Open in the dashboard

General payments

$1,938

57 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mohan Dutt of Sylvania, OH is reported in the CMS Open Payments database as having received $1,938 across 57 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 59th percentile of Sleep Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $771 29
2024 General $593 25
2023 General $117 1
2019 General $456 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohan Dutt
  • Sleep Medicine median
  • Middle half of Sleep Medicine
  • National median

In program year 2025, general payments to Mohan Dutt were reported at $771. Among 263 Sleep Medicine profiles paid that year, the median was $337 and the middle half received between $114 and $1,241.

Show as a table
Year Mohan Dutt Sleep Medicine median Middle half National median
2019 $456 $206 $79–$855 $163
2020 $0 $170 $48–$1,437 $114
2021 $0 $178 $53–$1,297 $132
2022 $0 $313 $95–$1,332 $149
2023 $117 $307 $117–$1,081 $160
2024 $593 $308 $100–$1,432 $164
2025 $771 $337 $114–$1,241 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inspire Medical Systems, Inc. $960 17 payments
  2. Harmony Biosciences LLC $289 10 payments
  3. Jazz Pharmaceuticals Inc. $251 8 payments
  4. Axsome Therapeutics, Inc. $118 7 payments
  5. Avadel CNS Pharmaceuticals, LLC $100 5 payments
  6. Itamar Medical Inc $40 1 payment
  7. Regeneron Healthcare Solutions, Inc. $38 2 payments
  8. Noctrix Health, Inc. $34 1 payment
  9. Takeda Pharmaceuticals U.S.A., Inc. $33 2 payments
  10. Pfizer Inc. $21 1 payment
  11. Other $54 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,453 55 payments
  2. Travel and Lodging $385 1 payment
  3. Education $100 1 payment
Products named General payments · program years 2019–2025
  1. INSPIRE $504 15 payments
  2. Inspire Upper Airway Stimulation System $456 2 payments
  3. XYWAV $251 8 payments
  4. WAKIX Narcolepsy $135 6 payments
  5. Sunosi $118 7 payments
  6. LUMRYZ $100 5 payments
  7. WAKIX Narcoplepsy $54 3 payments
  8. WatchPATONE $40 1 payment
  9. DUPIXENT $38 2 payments
  10. NIDRA $34 1 payment
  11. Other $151 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Sleep Medicine: 173

Drug cost

$36

Median for Sleep Medicine: $10,887

Branded share of claims

0%

Median for Sleep Medicine: 17.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Zolpidem Tartrate Generic 12 $36

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 723 Part D prescribers listed as Sleep Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$24,388

Medicare's payments for the services billed

Medicare patients

193

Average age 69

Services billed

276

89 women, 104 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Diabetes 31%
Ischemic heart disease 28%
Depression 25%
Atrial fibrillation 22%
Chronic kidney disease 21%
Heart failure 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XYWAV
  • JAZZ PHARMACEUTICALS INC. $103
$103 — —
WAKIX
  • Harmony Biosciences LLC $54
$54 — —
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $38
$38 — —
Sunosi
  • Axsome Therapeutics, Inc. $29
$29 — —
LUMRYZ
  • Avadel CNS Pharmaceuticals, LLC $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

57 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sleep Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record